Effectiveness of Negotiating Self-determination to Reduce Cigarette Consumption
The Effectiveness of Negotiating Self-Determination to Reduce Cigarette Consumption (NSD-RCC) Among Smokers Attending Outpatient Clinics: A Cluster Randomized Controlled Trial
1 other identifier
interventional
1,566
0 countries
N/A
Brief Summary
Background: Smokers attended to outpatient clinics present an excellent 'teachable moment' for smoking cessation interventions. This protocol paper describes the rationale and methods of a large randomized controlled trial which aims to evaluate the effectiveness of negotiating self-determination to reduce cigarette consumption among smokers attending outpatient clinics Methods: A randomized controlled trial will be conducted in 10 out-patient clinics in Hong Kong. Subjects in the intervention group will receive a brief intervention on smoking reduction plus a smoking reduction leaflet. Additionally, subjects will be asked to think about a smoking reduction schedule for themselves after the negotiation with the counsellor. Subjects in the control group will receive a brief advice on quitting plus a leaflet on smoking cessation. Four consecutive (1, 3, 6 and 12 months) follow-ups will be conducted. The primary outcome measure is biochemically validated abstinence at 6 months. Secondary outcomes are: (i) biochemically validated abstinence at 12 months, (ii) self-reported 7-day point prevalence of abstinence at 6 and 12 months, (iii) self-reported reduction of ≥ 50% in cigarette consumption at 6 and 12 months, and (iv) self-efficacy against tobacco at 6 and 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2021
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2016
CompletedFirst Posted
Study publicly available on registry
May 5, 2016
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedNovember 4, 2020
October 1, 2020
1.5 years
April 26, 2016
November 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
biochemically validated abstinence using exhaled CO test
6 months
Secondary Outcomes (9)
biochemically validated abstinence using exhaled CO test
12 months
self-reported 7-day point prevalence of abstinence
6 months
self-reported 7-day point prevalence of abstinence
12 months
self-reported reduction of ≥ 50% in cigarette consumption
6 months
self-reported reduction of ≥ 50% in cigarette consumption
12 months
- +4 more secondary outcomes
Study Arms (2)
Smoking reduction
EXPERIMENTALSubjects will receive a brief intervention on smoking reduction with a warning message plus a smoking reduction leaflet. They will be asked to think about a tailored smoking reduction schedule for themselves after the negotiation with the trained counsellor. The trained counsellor will negotiate a schedule with subjects to reduce their smoking over an acceptable level. For the subsequent telephone follow up in the intervention group, information on reduction and cessation will be collected, followed by a "booster" intervention, which will repeat the health warning to positively encourage them to reinforce their efforts and the next reduction target. Four consecutive (1, 3, 6 and 12 months) follow-ups will be conducted over the telephone by trained interviewers.
Smoking Cessation
PLACEBO COMPARATORSubjects in the QI group will always be advised to quit immediately rather than to quit progressively. Subjects will receive a brief advice on quitting with a warning message similar to subjects in the QP group. In addition, subjects will receive a self-help quitting pamphlet published by the Hong Kong Council on Smoking and Health (COSH). Unlike the QP group, subjects in the QI group will not receive smoking reduction intervention and leaflet, and "booster" intervention during telephone follow-ups. However, they will undergo a similar schedule of telephone follow-up as those in the QP group.
Interventions
A brief intervention on smoking reduction plus a smoking reduction leaflet
A brief advice on quitting plus a leaflet on smoking cessation
Eligibility Criteria
You may qualify if:
- smokers
- who are Chinese
- aged 18 years or above
- who smoke at least two cigarettes per day
- with moderate to severe nicotine dependence, and
- have no intention to quit smoking ≤7 days, but are interested in reducing the number of cigarettes smoked per day .
You may not qualify if:
- smokers
- with unstable medical conditions as advised by the doctor in charge,
- with poor cognitive state or mental illness,
- who participate in other smoking cessation programmes or services,
- with mild nicotine dependence, or
- who claim that they can quit ≤7 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William, Ho Cheung LI, PhD
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2016
First Posted
May 5, 2016
Study Start
June 1, 2021
Primary Completion
December 1, 2022
Study Completion
December 1, 2023
Last Updated
November 4, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share